Diamonds and Dogs


Allergan (AGN) jumping over 25% after agreeing to be bought out by AbbVie (ABBV) for approximately $63 billion, or $188.24 per share in cash & stock. The two companies are trying to diversify away from their two largest drugs, AbbVie's Humira drug for rheumatoid arthritis, the world's biggest-selling drug and Allergan's wrinkle reducer product, Botox. The deal is expected to generate significant annual operating cash flow of $19 billion, which will support a debt reduction target of $15 to $18 billion before the end of 2021, while also enabling a continued commitment to Baa2/BBB or better credit rating and continued dividend growth. This will be the third largest deal in the drug space within the last two years.

FedEx (FDX) can't win in the US/China trade tensions. FedEx is down 2% not far from a 52 low as China is considering adding FedEx to a list of so-called unreliable entities. FedEx drew the ire of Chinese officials after Huawei said that documents it asked to be shipped from Japan to China were instead diverted to the U.S. without authorization. The US government doesn't seem to be too happy with FedEx either. FedEx filed a lawsuit Tuesday against the U.S. Commerce Department, arguing the company shouldn't be held liable if it unknowingly ships items that violate the Trump administration's export restrictions, which were placed on Chinese telecommunications giant Huawei last month as the U.S.-China trade war escalated.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.